Research on the Anti-cerebral Ischemic Mechanism of Sailuotong Based on Network Pharmacology and Molecular Docking Technology
Objective:To explore the potential material basis and molecular mechanism of traditional Chinese medicine compound Sailuotong in the treatment of cerebral ischemic disease through network pharmacology and molecular docking technology.Methods:The active ingredients in the traditional Chinese medicine compound Sailuotong were obtained through literature,and the target of action of the active ingredients was predicted using TCMSP,SwissTargetPrediction,PharmMapper,and GeneCard databases.The corresponding gene targets for cere-bral ischemia were obtained by combining OMIM and DisGeNET databases.After the intersection of the two,a pro-tein interaction network(PPI)was constructed using String database and Cytoscape software,and analyzed to deter-mine the target of action with the highest Degree value ranking.Metascape tool was used to perform GO functional enrichment analysis and KEGG pathway enrichment analysis on the intersection targets of Sailuotong in the treat-ment of cerebral ischemia.Finally,molecular docking validation was performed using AutoDockTools software.Re-sults:The Sailuotong compound active compound target network for cerebral ischemic disease contained 301 tar-gets,with key targets involving Akt1,SRC,ESR1,GSK3B,EGFR,etc.The target gene function was biased towards substance metabolism,protein serine/threonine protein kinase activity,synaptic formation,inflammatory response,etc.The molecular docking results indicated that the main active ingredients in Sailuotong had a certain binding ability to key targets.Conclusion:Sailuotong may participate in neuroprotective effects after cerebral ischemia by regulating substance metabolism.